|
Modeled CA-125 kinetics during neoadjuvant chemotherapy for predicting the likelihood of optimal interval debulking surgery in ovarian cancer patients: Data from CHIVA trial (a GINECO study). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Halozyme |
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
Sophie Abadie Lacourtoisie |
No Relationships to Disclose |
|
|
|
Travel, Accommodations, Expenses - Roche |
|
|
Travel, Accommodations, Expenses - Merck; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Expert Testimony - AstraZeneca; Ipsen; Novartis; Tesaro |
Travel, Accommodations, Expenses - AstraZeneca; tesaro |
|
|
|
Travel, Accommodations, Expenses - Eisai; Novartis; PharmaMar; roche; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Pfizer |
|
Isabelle Laure Ray-Coquard |
Honoraria - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche; Tesaro |
Consulting or Advisory Role - Abbvie; Amgen; Genmab; Pfizer |
Travel, Accommodations, Expenses - Roche |
|
|
Consulting or Advisory Role - AstraZeneca |
Travel, Accommodations, Expenses - Chugai Pharma |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Pfizer; Roche; Sanofi; Tesaro |
Research Funding - Astellas Pharma; Janssen |
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Roche; tesaro |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; LEK; Novartis; Roche/Genentech; TESARO |
Research Funding - Merck Serono (Inst); Roche/Genentech (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Roche/Genentech |